STAT3 and Autosomal dominant hyper-IgE syndrome: Thus, due to dominant-negative mutations of STAT3, patients with autosomal dominant hyper-IgE syndrome have a defective Th17 (41) that is likely amplified on ECs where STAT3 mutation compromises the IL-22 effects.